Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimen... Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1847 | -10.8967551622 | 1.695 | 1.76 | 1.41 | 61811 | 1.55636154 | CS |
4 | -0.5997 | -28.4218009479 | 2.11 | 2.23 | 1.41 | 42404 | 1.7350697 | CS |
12 | -0.8897 | -37.0708333333 | 2.4 | 2.85 | 1.41 | 28473 | 2.06585904 | CS |
26 | -1.5097 | -49.9900662252 | 3.02 | 3.24 | 1.41 | 24642 | 2.41246796 | CS |
52 | -0.9297 | -38.1024590164 | 2.44 | 3.45 | 1.41 | 23084 | 2.6353111 | CS |
156 | -39.2897 | -96.2982843137 | 40.8 | 48 | 1.38 | 377644 | 10.30272347 | CS |
260 | -13.9357 | -90.2220639648 | 15.446 | 235.286 | 1.38 | 2159129 | 34.82529156 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales